Long-term safety and efficacy of deferasirox in patients with myelodysplastic syndrome, aplastic anemia and other rare anemia in Taiwan

Objective: Patients with myelodysplastic syndromes (MDS), aplastic anemia (AA) or other rare anemia require chronic blood transfusions which can lead to iron overload and subsequent excess iron-mediated complications. Intensive iron chelation with deferasirox could remove excess iron and can allevia...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Hematology (Luxembourg) 2019-01, Vol.24 (1), p.247-254
Hauptverfasser:	Ko, Bor-Sheng, Chang, Ming-Chih, Chiou, Tzeon-Jye, Chang, Te-Kau, Chen, Yeu-Chin, Lin, Sheng-Fung, Chang, Cheng-Shyong, Lu, Yin-Che, Yeh, Su-Peng, Chen, Tsai-Yun, Hwang, Wei-Shou
Format:	Artikel
Sprache:	eng
Schlagworte:	Adverse events Aged Aged, 80 and over Anemia, Aplastic - blood Anemia, Aplastic - complications Anemia, Aplastic - drug therapy Anemia, Aplastic - epidemiology aplastic anemia deferasirox Deferasirox - administration & dosage Deferasirox - adverse effects erythroid response Female Follow-Up Studies Gastrointestinal Diseases - chemically induced Gastrointestinal Diseases - epidemiology Humans iron chelation Iron Overload - blood Iron Overload - drug therapy Iron Overload - epidemiology Iron Overload - etiology Male Middle Aged myelodysplastic syndrome Myelodysplastic Syndromes - blood Myelodysplastic Syndromes - complications Myelodysplastic Syndromes - drug therapy Myelodysplastic Syndromes - epidemiology Skin Diseases - chemically induced Skin Diseases - epidemiology Taiwan - epidemiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!